# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
NanoString, now a Bruker business, will promptly seek an end to the injunction impacting sales of CosMx SMI products in Germany...
15 large-cap stocks had a rough week, with CVS, Starbucks, and DoorDash all taking major hits. Analysts have lowered price targ...
Fiscal Year 2024 Financial Outlook Bruker's FY 2024 updated guidance now includes the expected benefits of the Chemspeed a...
Bruker (NASDAQ:BRKR) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.46 by 15.22...
Last week's worst performers included Arm Holdings, Coinbase Global, Live Nation Entertainment and J.B. Hunt Transport Serv...
Following the closing, NanoString's business operations will no longer be the subject of a chapter 11 proceeding and will b...
Goldman Sachs analyst Matthew Sykes maintains Bruker (NASDAQ:BRKR) with a Sell and raises the price target from $66 to $74.